FDA approves first generic version of epilepsy drug Sabril from Teva
FDA Warns Against Use of Fake ADHD Drug Adderall
FDA warning letter says Teva China plant has more work to do on API issues | FiercePharma
Teva Pharmaceutical Works, 10/16 - Validation Center
Teva China API plant smacked by FDA warning letter, adding to drugmaker's burdens
Teva confirms US FDA warning letter for Hangzhou, China API plant
FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen | tctmd.com
Celltrion FDA warning causes headache for Teva's biologics ambition
Teva's rating cut to junk, Two Lupin facilities receive FDA warning letters | Radio Compass Blog
Teva confident in September approval for migraine drug despite latest Celltrion plant citation - PSC Biotech Singapore
Teva recalls U.S.-made drugs following contamination fears | Pittsburgh Post-Gazette
FDA Approves Biosimilar, But it Comes with a Severe Label Warning | Packaging World
Teva sues FDA for changing 'first applicant' definition for generics
Teva's troubled Godollo plant earns firm US FDA warning letter
FDA issues warning about counterfeit Adderall purchased online | KATV
FDA issues warning on heart-related side effects of malaria drug for COVID-19 - UPI.com
Lawsuits Mount Over Cancer Drug's FDA Black Box Warning - Drug And Device Watch
US FDA eases Teva headache with Ajovy approval
FDA cautions against wide use of hydroxychloroquine, drug Trump touted
FDA предупреждает «Teva» о существенных нарушениях на производстве | Еженедельник АПТЕКА
Teva wins FDA nod for sublingual film to treat opioid dependence - Drug Delivery Business
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | FiercePharma
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Israel's Teva on FDA blacklist of drugmakers creating barriers to competition | The Times of Israel
